A Comparison of the Estimates of Fuwai and Reynolds Risk Model

Coronary Heart Disease and Stroke Clinical Trial

Official title:

A Comparison of the Estimates of Fuwai and Reynolds Risk Model

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02241239
• Other study ID #: 2014-0901-1
• Status: Recruiting
• Phase: N/A
• First received: August 31, 2014
• Last updated: November 5, 2014
• Start date: August 2014
• Est. completion date: December 2014

Study information

• Verified date: August 2014
• Source: Wuhan Asia Heart Hospital
• Contact: Youping Chen, M.D,
• Phone: +86-27-65796888
• Email: sageeeee[@]163.com
• Is FDA regulated: No
• Health authority: China: Ministry of Health
• Study type: Observational

Clinical Trial Summary

There are many risk prediction models. And their estimates are different. This study aimed to investigate the differences between the estimates of Fuwai and Reynolds risk model in Chinese, and investigate the reason for the differences.

Description:

The participants will examined for cardiovascular risk factors, and their cardiovascular risks will be calculated based on the values of the risk factors using cardiovascular risk models. The estimates of different risk models will be compared, and the levels of traditional risk factors will be adjusted in order to evaluate the impacts of uncommon risk factors such as social and genetic risk factors.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria: adults -

Exclusion Criteria: with coronary heart disease

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Coronary Heart Disease and Stroke
• Myocardial Ischemia

Locations

Country	Name	City	State
China	Wuhan Asia Heart Hospital	Wuhan	Hubei
China	Wuhan Asia Heart Hospital	Wuhan

Sponsors (1)

Lead Sponsor	Collaborator
Wuhan Asia Heart Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	cardiovascular risk	The cardiovascular risk is the probability of the occurrence of coronary heart disease and stroke. The cardiovascular risk is calculated by risk prediction models based on the patient's risk factors.	1 day	No